


BIO3S Revenue
Biotechnology Research • #102, Agricultural Business Incubator, Korea, Republic of • 1-10 Employees
BIO3S revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Key Contact at BIO3S
Duwoon Kim
Chief Executive Officer
Company overview
| Headquarters | #102, Agricultural Business Incubator, 77 Yongbong-Ro, Buk-Gu, Gwangju, KR |
| Website | |
| Founded | 2016 |
| Employees | 1-10 |
About BIO3S
To develop a technology that responds to the demand of consumers who want to collect SARSCoV-2 samples without pain, BIO3S, Inc. has a novel "Oral and Nasal Virus Clinical Collection(OVC) technology", for highly sensitive self-diagnosis of COVID-19. The Salivfix solution is onestep technology that does not require additional steps such as antigen extract step and RNA extraction step in an antigen rapid diagnostic tests (Ag-RDTs) and PCR analysis, respectively. BIO3S, Inc. completed clinical trial in comparing the sensitivity and specificity of collecting virus from COVID-19 patients' mouth using OVC technology, in comparison to collecting virus with conventional nasopharyngeal swab (NPS). We hope our OVC technology leads the self-testing market to diagnosis of respiratory viral infectious disease.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
BIO3S has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
BIO3S has never raised funding before.
Frequently asked questions
4.8
40,000 users



